Gallant-1: Gb1211 Galectin-3 (Gal-3) Inhibitor Plus Atezolizumab (Atz) For First Line Treatment In Patients (Pts) With Advanced/Metastatic Non-Small Cell Lung Cancer (Nsclc)
Atezolizumab;GB-1211
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Gallant-1: Gb1211 Galectin-3 (Gal-3) Inhibitor Plus Atezolizumab (Atz) For First Line Treatment In Patients (Pts) With Advanced/Metastatic Non-Small Cell Lung Cancer (Nsclc) ### Output: Atezolizumab;GB-1211